Home/Filings/4/0001447028-21-000008
4//SEC Filing

Howard Elizabeth 4

Accession 0001447028-21-000008

CIK 0001447028other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:57 PM ET

Size

8.6 KB

Accession

0001447028-21-000008

Insider Transaction Report

Form 4
Period: 2021-02-13
Howard Elizabeth
Exec. VP & General Counsel
Transactions
  • Award

    Stock Options

    2021-02-13+200,000200,000 total
    Exercise: $4.33Exp: 2031-02-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001669530

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:57 PM ET
Size
8.6 KB